These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25866764)

  • 1. Construction of a CXCL12-KDEL fusion gene to inhibit head and neck squamous cell carcinoma metastasis by intracellular sequestration of CXCR4.
    Zhang W; Wang X; Yue K; Liu S; Liu X
    Biomed Res Int; 2015; 2015():195828. PubMed ID: 25866764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Knockout of CXCR4 Expression by a Novel Intrakine Mutant hSDF-1α/54/KDEL Inhibits Breast Cancer Metastasis.
    Chen HY; Clayman ES; Ma WF
    J Interferon Cytokine Res; 2015 Oct; 35(10):771-8. PubMed ID: 25978539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
    Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
    Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma.
    León X; Diez S; García J; Lop J; Sumarroca A; Quer M; Camacho M
    Eur Arch Otorhinolaryngol; 2016 Dec; 273(12):4525-4533. PubMed ID: 27328961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of CXCL12 and CXCR4 in lymph node metastases and development of oral squamous cell carcinomas.
    Oliveira-Neto HH; Silva ET; Leles CR; Mendonça EF; Alencar Rde C; Silva TA; Batista AC
    Tumour Biol; 2008; 29(4):262-71. PubMed ID: 18781098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12 and CXCR4, but not CXCR7, are primarily expressed by the stroma in head and neck squamous cell carcinoma.
    Clatot F; Cornic M; Berghian A; Marchand V; Choussy O; El Ouakif F; François A; Ruminy P; Laberge-Le-Couteulx S; Picquenot JM; Jardin F
    Pathology; 2015 Jan; 47(1):45-50. PubMed ID: 25474514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
    Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
    Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression and significance of SDF-1/CXCR4 biological axis in laryngeal squamous cell carcinoma and lymph node metastasize].
    Zhang L; Xiong C; Wu Y; Shi H; Jing S; Song J; Zhao Z; Shan B
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):798-801. PubMed ID: 23259294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
    Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
    Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma.
    Samara GJ; Lawrence DM; Chiarelli CJ; Valentino MD; Lyubsky S; Zucker S; Vaday GG
    Cancer Lett; 2004 Oct; 214(2):231-41. PubMed ID: 15363550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CC-chemokine receptor 7 (CCR7) and CXC-chemokine receptor 4 (CXCR4) in head and neck squamous cell carcinoma.
    Ueda M; Shimada T; Goto Y; Tei K; Nakai S; Hisa Y; Kannagi R
    Auris Nasus Larynx; 2010 Aug; 37(4):488-95. PubMed ID: 20036791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of integrin αvβ3, CXC chemokine receptor 4 and CXC chemokine receptor 7 and their relationship with lymph node metastasis in squamous cell carcinoma of head and neck].
    Li P; Li WL; Qi JX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Dec; 52(12):723-729. PubMed ID: 29275565
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of chemokine receptor CXCR4 and its ligand CXCL12 in the process of proliferation and migration of oral squamous cell carcinoma].
    Yin D; Zhang Z; Gao S; Li B
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2013 Feb; 31(1):8-12. PubMed ID: 23484292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway.
    Tan CT; Chu CY; Lu YC; Chang CC; Lin BR; Wu HH; Liu HL; Cha ST; Prakash E; Ko JY; Kuo ML
    Carcinogenesis; 2008 Aug; 29(8):1519-27. PubMed ID: 18487224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
    Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
    J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
    Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
    J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma.
    Almofti A; Uchida D; Begum NM; Tomizuka Y; Iga H; Yoshida H; Sato M
    Int J Oncol; 2004 Jul; 25(1):65-71. PubMed ID: 15201990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.